Condition
Organoid clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Organoid clinical trials that are recruiting, at sites in 5 countries (most in Italy (1), France (1), China (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 5Countries
Newest Organoid clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Organoid Drug Sensitivity-Guided Therapy for Refractory Tumors | — | Tianjin, Tianjin Municipality | Recruiting | Oct 30, 2026 |
| Duodenal organoids to study how the gut lining interacts with pathogens | — | Negrar, Verona | Recruiting | Sep 18, 2026 |
| Testing drug responses using glioblastoma organoids | — | Daejeon, Chungcheongnam-do | Recruiting | Jan 20, 2025 |
| Collecting tumor samples from triple-negative breast cancer patients to explore new treatments and biomarkers. | — | Caen | Recruiting | Jun 3, 2022 |
| Using patient-derived organoids to predict lung cancer treatment response | — | Geneva | Recruiting | Jun 7, 2019 |
All recruiting trials (5)
-
Organoid Drug Sensitivity-Guided Therapy for Refractory Tumors
This study tests whether tumor organoids created from a patient’s tissue can help doctors pick drugs for adults with hard‑to-treat, unresectable, or metastatic cancers after standard options have been exhausted.
-
Duodenal organoids to study how the gut lining interacts with pathogens
Researchers are using tissue from patients who have part of their duodenum removed to grow living 3D organoids and test how the intestinal epithelium responds to pathogens in the lab.
-
Testing drug responses using glioblastoma organoids
This study is testing if lab-grown brain tumor samples from patients can help predict how well different drugs will work for their glioblastoma treatment.
-
Collecting tumor samples from triple-negative breast cancer patients to explore new treatments and biomarkers.
This study is collecting tumor samples from people with triple-negative breast cancer to see if new treatments and markers can help improve their care.
-
Using patient-derived organoids to predict lung cancer treatment response
This study is testing if tiny lab-grown versions of lung tumors can help doctors figure out which cancer treatments will work best for patients.
Related topics
Quick answers
How many Organoid clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Italy (1 trial), France (1 trial), China (1 trial), South Korea (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.